Track topics on Twitter Track topics that are important to you
With backing from its syndicate’s five investors, Renovacor is eyeing an IND submission.
Temple University spinout Renovacor gained $11 million from a Series A funding round, which the company will use to advance d -More-
- Funding supports preclinical development through IND submission for its BAG3 gene therapy, the first gene replacement product for genetic forms of dilated cardiomyopathy - Company announces lead...
We have published hundreds of Renovacor news stories on BioPortfolio along with dozens of Renovacor Clinical Trials and PubMed Articles about Renovacor for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Renovacor Companies in our database. You can also find out about relevant Renovacor Drugs and Medications on this site too.